Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case

This article describes a case of successfully used tocilizumab (interleukin 6 receptors monoclonal antibodies) in a two-year patient with severe systemic juvenile idiopathic arthritis resistant to oral and parenteral glucocorticoids, nonsteroidal anti-inflammatory drugs, and methotrexate. Just after...

Full description

Bibliographic Details

Published in:	Педиатрическая фармакология
Main Authors:	E. I. Alekseeva, S. I. Valieva, T. M. Bzarova, R. V. Denisova, T. V. Sleptsova, O. L. Lomakina, A. M. Chomakhidze
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2016-11-01
Subjects:	tocilizumab juvenile idiopathic arthritis children
Online Access:	https://www.pedpharma.ru/jour/article/view/1447